723/726 Proof of Concept Study in Allergen Challenge Chamber in Hannover

NCT00972504 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
54
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

GlaxoSmithKline